• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卡介苗治疗膀胱浅表肿瘤]

[BCG therapy of superficial tumors of the bladder].

作者信息

Prapotnich D

机构信息

Institut mutualiste Montsouris, Paris.

出版信息

Bull Cancer. 1998 Feb;85(2):135-9.

PMID:9752330
Abstract

Superficial bladder tumor defined as pTa, pT1 and pTis stage is one of the most common cancer disease in the world. Intravesical BCGtherapy represents the best treatment when combined with transurethral resection to prevent tumor recurrence or progression and to lengthen the interval between recurrence. The toxicity is quite important but can be reduced by using the good procedure. Local or general immunostimulation is likely to be the exact mechanism of action but more data are needed.

摘要

表浅性膀胱肿瘤定义为pTa、pT1和pTis期,是世界上最常见的癌症疾病之一。膀胱内卡介苗治疗与经尿道切除术联合使用时,是预防肿瘤复发或进展以及延长复发间隔的最佳治疗方法。其毒性相当大,但可以通过采用恰当的程序来降低。局部或全身免疫刺激可能是确切的作用机制,但还需要更多数据。

相似文献

1
[BCG therapy of superficial tumors of the bladder].[卡介苗治疗膀胱浅表肿瘤]
Bull Cancer. 1998 Feb;85(2):135-9.
2
[Clinical experience with BCG immune prevention in superficial bladder cancer].
Urologe A. 1992 Sep;31(5):296-301.
3
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.膀胱内卡介苗联合癌症疫苗可增强非肌层浸润性膀胱癌患者的局部 T 细胞应答。
Clin Cancer Res. 2017 Feb 1;23(3):717-725. doi: 10.1158/1078-0432.CCR-16-1189. Epub 2016 Aug 12.
4
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况:丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.
5
Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.卡介苗膀胱内免疫治疗后T1期3级膀胱移行细胞癌的复发与进展
J Urol. 2000 Jun;163(6):1697-701.
6
[Treatment and follow-up of superficial bladder cancer].[浅表性膀胱癌的治疗与随访]
Duodecim. 2002;118(9):903-9.
7
Management of high-risk non-muscle invasive bladder cancer.高危非肌层浸润性膀胱癌的管理
Minerva Urol Nefrol. 2012 Dec;64(4):255-60.
8
A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer.
J Urol. 1996 Sep;156(3):972-4. doi: 10.1016/s0022-5347(01)65675-1.
9
Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer.卡介苗膀胱内灌注治疗T1期浅表性膀胱癌
Urol Int. 2008;80(1):74-9. doi: 10.1159/000111734. Epub 2008 Jan 18.
10
Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.经尿道切除浅表性膀胱癌后卡介苗的免疫预防性膀胱内应用。
Croat Med J. 2003 Apr;44(2):187-92.